 BOSTON, Dec. 06, 2022 GLOBE NEWSWIRE X4 Pharmaceuticals, Inc. Nasdaq: XFOR, a leader in the discovery and development of novel small-molecule therapeutics to benefit people with diseases of the immune system, announced today that it has commenced an underwritten public offering of shares of its common stock or pre-funded warrants to purchase its common ... The post X4 Pharmaceuticals Announces Proposed Public Offering appeared first on ForexTV... 